{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:20:27Z","timestamp":1792898427433,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.humpath.2021.05.010","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T11:26:13Z","timestamp":1622201173000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["RNAscope CSF1 chromogenic in situ hybridization: a potentially useful tool in the differential diagnosis of tenosynovial giant cell tumors"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1046-0153","authenticated-orcid":false,"given":"Judith Jebastin","family":"Thangaiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2151-1929","authenticated-orcid":false,"given":"Justin W.","family":"Koepplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Folpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2021.05.010_bib1","first-page":"731","article-title":"Pigmented villonodular synovitis, bursitis and tenosynovitis","volume":"31","author":"Jaffe","year":"1941","journal-title":"Arch Pathol"},{"key":"10.1016\/j.humpath.2021.05.010_bib2","series-title":"Enzinger & weiss's soft tissue tumors","author":"Goldblum","year":"2019"},{"key":"10.1016\/j.humpath.2021.05.010_bib3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0046-8177(97)90155-6","article-title":"Giant cell tumor of tendon sheath is a polyclonal cellular proliferation","volume":"28","author":"Vogrincic","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.05.010_bib4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/gcc.2870060404","article-title":"Chromosome aberrations in tenosynovial giant cell tumors and nontumorous synovial tissue","volume":"6","author":"Mertens","year":"1993","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2021.05.010_bib5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0046-8177(94)90154-6","article-title":"Diffuse-variant tenosynovial giant cell tumor: a rare and aggressive lesion","volume":"25","author":"Rowlands","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.05.010_bib6","first-page":"3986","article-title":"Cytogenetic characterization of tenosynovial giant cell tumors (nodular tenosynovitis)","volume":"54","author":"Dal Cin","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2021.05.010_bib7","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00428-002-0640-y","article-title":"Molecular cytogenetic mapping of recurrent chromosomal breakpoints in tenosynovial giant cell tumors","volume":"441","author":"Nilsson","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2021.05.010_bib8","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1073\/pnas.0507321103","article-title":"A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells","volume":"103","author":"West","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2021.05.010_bib9","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/PAS.0b013e31802b86f8","article-title":"Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides","volume":"31","author":"Cupp","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.010_bib10","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3892\/ijo.2014.2326","article-title":"Novel CSF1-S100A10 fusion gene and CSF1 transcript identified by RNA sequencing in tenosynovial giant cell tumors","volume":"44","author":"Panagopoulos","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.humpath.2021.05.010_bib11","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1002\/ijc.32421","article-title":"Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutations","volume":"145","author":"Tsuda","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2021.05.010_bib12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0046-8177(92)90340-9","article-title":"Diffuse and localized tenosynovial giant cell tumor and pigmented villonodular synovitis: a clinicopathologic and flow cytometric DNA analysis","volume":"23","author":"Abdul-Karim","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.05.010_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00000478-200004000-00002","article-title":"Diffuse-type giant cell tumor: clinicopathologic and immunohistochemical analysis of 50 cases with extraarticular disease","volume":"24","author":"Somerhausen","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.010_bib14","series-title":"WHO classification of tumours of soft tissue and bone","author":"Fletcher","year":"2013"},{"key":"10.1016\/j.humpath.2021.05.010_bib15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41379-018-0129-0","article-title":"Malignant tenosynovial giant cell tumor: the true \"synovial sarcoma?\" A clinicopathologic, immunohistochemical, and molecular cytogenetic study of 10 cases, supporting origin from synoviocytes","volume":"32","author":"Al-Ibraheemi","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.05.010_bib16","first-page":"939","article-title":"Tenosynovial giant cell tumors: evidence for a desmin-positive dendritic cell subpopulation","volume":"11","author":"Folpe","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.05.010_bib17","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1097\/PAS.0b013e3181a6d86f","article-title":"Clusterin is expressed in normal synoviocytes and in tenosynovial giant cell tumors of localized and diffuse types: diagnostic and histogenetic implications","volume":"33","author":"Boland","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.010_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/his.13744","article-title":"Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?","volume":"74","author":"Mastboom","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2021.05.010_bib19","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1158\/1078-0432.CCR-08-0252","article-title":"Immunohistochemical and biogenetic features of diffuse-type tenosynovial giant cell tumors: the potential roles of cyclin A, P53, and deletion of 15q in sarcomatous transformation","volume":"14","author":"Huang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2021.05.010_bib20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","article-title":"RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues","volume":"14","author":"Wang","year":"2012","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.humpath.2021.05.010_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/PAS.0000000000000290","article-title":"A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors","volume":"39","author":"Carter","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.010_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0002-9440(10)63279-8","article-title":"The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status","volume":"165","author":"West","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2021.05.010_bib23","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.2353\/ajpath.2009.081037","article-title":"Coordinate expression of colony-stimulating factor-1 and colony-stimulating factor-1-related proteins is associated with poor prognosis in gynecological and nongynecological leiomyosarcoma","volume":"174","author":"Espinosa","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2021.05.010_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/labinvest.2014.1","article-title":"Colony-stimulating factor 1 potentiates lung cancer bone metastasis","volume":"94","author":"Hung","year":"2014","journal-title":"Lab Invest"},{"key":"10.1016\/j.humpath.2021.05.010_bib25","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jtcvs.2014.05.003","article-title":"Interstitial tumor-associated macrophages combined with tumor-derived colony-stimulating factor-1 and interleukin-6, a novel prognostic biomarker in non-small cell lung cancer","volume":"148","author":"Pei","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.humpath.2021.05.010_bib26","first-page":"113","article-title":"[Expression of colony-stimulating factor 1 in lung adenocarcinoma and its prognostic implication]","volume":"37","author":"Pei","year":"2015","journal-title":"Zhonghua Zhongliu Zazhi"},{"key":"10.1016\/j.humpath.2021.05.010_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091142","article-title":"HPV E6\/E7 RNA in situ hybridization signal patterns as biomarkers of three-tier cervical intraepithelial neoplasia grade","volume":"9","author":"Evans","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2021.05.010_bib28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/modpathol.2017.142","article-title":"Ultrasensitive automated RNA in situ hybridization for kappa and lambda light chain mRNA detects B-cell clonality in tissue biopsies with performance comparable or superior to flow cytometry","volume":"31","author":"Guo","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.05.010_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099131","article-title":"In situ quantitative measurement of HER2mRNA predicts benefit from trastuzumab-containing chemotherapy in a cohort of metastatic breast cancer patients","volume":"9","author":"Vassilakopoulou","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2021.05.010_bib30","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1158\/1078-0432.CCR-17-0299","article-title":"Age and gender associations of virus positivity in Merkel cell carcinoma characterized using a novel RNA in situ hybridization assay","volume":"23","author":"Wang","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2021.05.010_bib31","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/01.pas.0000112536.76973.7f","volume":"28","author":"Grogg","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.010_bib32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/modpathol.3800294","article-title":"A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tumor","volume":"18","author":"Grogg","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.05.010_bib33","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2147\/DDDT.S253232","article-title":"Pexidartinib, a novel small molecule CSF-1R inhibitor in use for tenosynovial giant cell tumor: a systematic Review of pre-clinical and clinical development","volume":"14","author":"Benner","year":"2020","journal-title":"Drug Des Devel Ther"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721000952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721000952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:38:17Z","timestamp":1758645497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817721000952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":33,"alternative-id":["S0046817721000952"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2021.05.010","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNAscope CSF1 chromogenic in situ hybridization: a potentially useful tool in the differential diagnosis of tenosynovial giant cell tumors","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2021.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}